PerkinElmer, Inc. (PKI) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Waltham, MA, United States. The current CEO is Prahlad R. Singh.
PKI has IPO date of 1983-04-06, 16,700 full-time employees, listed on the NYSE, a market capitalization of $14.46B.
PerkinElmer, Inc. is a global provider of products, services, and solutions serving the diagnostics, life sciences, and applied services markets. Operating through two main segments—Discovery & Analytical Solutions and Diagnostics—the company offers a comprehensive portfolio including reagents, analytical instrumentation, imaging technologies, and diagnostic platforms for genetic disorder detection and infectious disease testing. Its Discovery & Analytical Solutions segment serves life sciences researchers and provides environmental, food, and industrial testing capabilities, while its Diagnostics segment delivers early detection solutions for genetic abnormalities and infectious diseases. Founded in 1937 and headquartered in Waltham, Massachusetts, PerkinElmer serves pharmaceutical companies, biotechnology firms, laboratories, academic institutions, healthcare organizations, and government agencies worldwide.
